Pharmacokinetics and Immunogenicity of ASP0113 in CMV‐Seronegative Dialysis Patients and CMV‐Seronegative and ‐Seropositive Healthy Subjects-Reference-Cited by-同舟云学术

Pharmacokinetics and Immunogenicity of ASP0113 in CMV‐Seronegative Dialysis Patients and CMV‐Seronegative and ‐Seropositive Healthy Subjects

Published:2020-03-23 Issue:4 Volume:9 Page:444-455
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Bonate Peter L.¹,Van Sant Charles²,Cho Kathy¹,Zook Erin C.¹,Smith Larry R.³,Boutsaboualoy Sou³,Ye Ming³,Wang Xuegong¹,Wu Ruishan¹,Koester Anne⁴,Rammelsberg Diane⁵,Goldwater Ronald⁴,Marbury Thomas C.⁶

Affiliation:

1. Astellas Pharma Global Development, Inc Northbrook Illinois USA

2. Astellas Research Institute of America Northbrook Illinois USA

3. Vical Inc San Diego California USA

4. Parexel International Baltimore Maryland USA

5. Randstad Pharma Deerfield Illinois USA

6. Orlando Clinical Research Center Orlando Florida USA

Funder

Astellas Pharma Global Development

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.792

Reference48 articles.

1. Double-Stranded DNA (dsDNA) Viral Infections Among Allogeneic Hematopoietic Cell Transplant (HCT) Recipients in the First Year after Transplant

2. The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality

3. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis

4. The pathogenesis of human cytomegalovirus

5. Infection in Solid-Organ Transplant Recipients

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective approaches to gene therapy computational modeling – spotlight on viral gene therapy;Journal of Pharmacokinetics and Pharmacodynamics;2023-10-17

2. Cytomegalovirus Vaccines;Plotkin's Vaccines;2023

3. Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development;Annual Review of Virology;2022-09-29